Chemobrain: Experts Weigh in on Very Real — and Growing — Problem
Major advances in cancer treatment in recent decades have allowed patient survival rates to increase.
Supportive Care
Additional Method of Administration Approved for Cinvanti in Chemotherapy-Induced Nausea and Vomiting
Heron Therapeutics announced that the Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for Cinvanti (aprepitant) to expand administration to include a 2-minute intravenous (IV) injection, in addition to the already approved 30-minute IV infusion.
Managing Chemotherapy- and Radiation Therapy-Induced Nausea and Vomiting
CINV and RINV are a frequent source of misery and distress for patients and ineffective emesis control has well-documented impacts on health-related quality of life.
Oral Mucositis: Chemotherapy-Associated Toxicity
Patients who receive chemotherapy or radiation therapy are at risk for developing oral mucositis, which causes inflammatory and/or ulcerative lesions of the oral mucosa
Non-Drug Costs of CAR-T Cell Therapy May Exceed $50,000
Researchers noted that while non-drug costs account for only 7% of CAR-T therapy-related expenses, these costs may range from $30,000 to $56,000.
Late-Onset Toxicity Possible With Immunotherapy
Postapproval studies are needed to further characterize the risk and long-term safety of immune checkpoint inhibition.
Immunotherapy and the Risk of Myocarditis
The risk should not discourage patients with cancer from taking these potentially life-extending therapies.
Managing Adverse Events in the Era of Immunotherapy
The novelty of immunotherapies means that physicians and patients lack extensive experience dealing with them.
In the Clinic: Managing Malignant Pleural Effusions
Management of malignant pleural effusions should be tailored to the particular patient, depending on preference, prognosis, and variety of underlying disease.
Does Depression Increase the Risk for Mortality Among Patients With Cancer?
As failure to recognize depression symptoms contributes to the association between mortality and depression in cancer patients, early recognition and treatment with pharmacologic and/or psychologic support is essential for improving outcomes.
- Loading...
Loading...
Want to read more?
Please login or register first to view this content.
Next post in Side Effect Management
Loading... 
Loading...